Literature DB >> 14837538

A hormonal neurogenic vasopressor mechanism.

R D TAYLOR, I H PAGE, A C CORCORAN.   

Abstract

Keywords:  BRAIN

Mesh:

Substances:

Year:  1951        PMID: 14837538     DOI: 10.1001/archinte.1951.03810070011001

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN: 0888-2479


× No keyword cloud information.
  10 in total

1.  Vaso-motor factor in glaucoma.

Authors:  E G MACKIE
Journal:  Br J Ophthalmol       Date:  1958-01       Impact factor: 4.638

2.  Some neurophysiological aspects of serotonin.

Authors:  D W WOOLLEY; E SHAW
Journal:  Br Med J       Date:  1954-07-17

3.  Studies on hydralazine; evidence for a peripheral site of action.

Authors:  A STUNKARD; L WERTHEIMER; W REDISCH
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

4.  Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline).

Authors:  E L WILKINSON; H BACKMAN; H H HECHT
Journal:  J Clin Invest       Date:  1952-10       Impact factor: 14.808

5.  Effect of hydralazine in hypertension.

Authors:  M A KHAN
Journal:  Br Med J       Date:  1953-01-03

6.  The effects of 1-hydrazinophthalazine on cerebral blood flow, vascular resistance, oxygen uptake and jugular oxygen tension in hypertensive subjects.

Authors:  J H HAFKENSCHIEL; C K FRIEDLAND
Journal:  J Clin Invest       Date:  1953-07       Impact factor: 14.808

7.  A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

Authors:  D W Woolley; E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  1954-04       Impact factor: 11.205

8.  Endocrine factors in hypertension.

Authors:  G A PERERA
Journal:  Bull N Y Acad Med       Date:  1952-01

9.  Humoral and vasomotor controls of blood vessels.

Authors:  I H PAGE
Journal:  Bull N Y Acad Med       Date:  1952-03

10.  Hemodynamic effects of 1-hydrazinophthalazine (apresoline) in human pregnancy: results of intravenous administration.

Authors:  N S ASSALI; S KAPLAN; S OIGHENSTEIN; R SUYEMOTO
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.